SCHEMBL2908535

SCHEMBL2908535

CCN(CC)Cc1cn(-c2ccc(-c3ccc(OC)cc3)cc2)nc1-c1ccco1.Fc1ccccc1-c1nn(-c2ccccc2)cc1CN1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
KDM4E B2RXH2 8/20 0.43
LMNA P02545 2/20 0.43
KDM5B Q9UGL1 2/20 0.41
MAPT P10636 6/20 0.41
GAA P10253 1/20 0.40
SSTR5 P35346 2/20 0.40
HTT P42858 2/20 0.40
POLB P06746 3/20 0.40
GLA P06280 1/20 0.40
KMT2A Q03164 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
SLC2A1 P11166 1/20 0.38
MEN1 O00255 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2908994 0.84 ALDH1A1 (0.52) ALDH1A1KDM4ELMNAKDM5BMAPT
SCHEMBL2902803 0.82 KDM4E (0.48) ALDH1A1KDM4EMAPTHTTPOLB
SCHEMBL2908931 0.78 ALDH1A1 (0.49) ALDH1A1KDM4ELMNAKDM5BSSTR5
SCHEMBL2903263 0.77 ALDH1A1 (0.48) ALDH1A1KDM4ELMNAMAPTGAA
SCHEMBL2902823 0.76 ALDH1A1 (0.64) ALDH1A1KDM4ELMNAKDM5BMAPT
SCHEMBL2906130 0.76 CYP2A13 (0.53) ALDH1A1KDM4ELMNAKDM5BMAPT
SCHEMBL2905922 0.75 ALDH1A1 (0.52) ALDH1A1KDM4ELMNAMAPTGAA
SCHEMBL2901798 0.75 MAPT (0.50) ALDH1A1KDM4ELMNAMAPTGAA
SCHEMBL2902226 0.74 SSTR5 (0.49) ALDH1A1KDM4ELMNAKDM5BMAPT
SCHEMBL2902611 0.73 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611107-B1 1,3,4-SUBSTITUTED PYRAZOLES FOR USE AS 5-HT RECEPTOR ANTAGONISTS IN THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS MERCK PATENT GMBH (DE) 2010-08-18 EP claimed